An Act protecting patient safety regarding non-FDA approved drugs

HD 1476 prohibits retail pharmacies from reselling custom-made compounded medications (prepared for individual patients per prescription) and requires these drugs to be dispensed only to the specific patient for whom they were compounded. The bill mandates specific labeling requirements, including "not for resale" or "office use only" statements, and detailed information like ingredients, expiration dates, and handling instructions. It directly affects retail pharmacies and outsourcing facilities that prepare compounded drugs, subjecting violations to disciplinary actions by the state Pharmacy Board. The law aims to prevent unsafe distribution by restricting resale and ensuring proper labeling for patient safety.